about
The interplay of autoimmunity and insulin resistance in type 1 diabetesDiabetic cardiomyopathy: signaling defects and therapeutic approachesRenal outcomes of bariatric surgery in obese adults with diabetic kidney disease.Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.Glucagon supports postabsorptive plasma glucose concentrations in humans with biologically optimal insulin levels.Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled studyInsulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI studyTLR4-dependent metabolic changes are associated with cognitive impairment in an animal model of type 1 diabetes.Cardiovascular risk in double diabetes mellitus--when two worlds collide.The multiple origins of Type 1 diabetes.The prenatal environment and type 1 diabetes.Management of patients with type 1 diabetes in the hospital.Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats.Low-intensity pulsed ultrasound prevents muscle atrophy induced by type 1 diabetes in rats.A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients.Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.Insulin sensitizer prevents and ameliorates experimental type 1 diabetes.
P2860
Q26823862-A07B52A1-DA32-4281-AD28-0C72FEE274DAQ28395852-28E62F8E-6EE1-4845-BCA7-1AAF207A6D4BQ30360386-78E69F36-A59D-4D19-A442-B2338DA589D5Q33930217-90651C56-948B-4A37-8F76-D7754491AA50Q34237762-CAEF3F50-239B-4F38-9A22-8BB9302304DDQ34288242-12DD450F-855B-4FC3-913C-91344CDD4F71Q34448739-D47AB9A5-8290-49CE-9B68-9635BD8A78AAQ37562669-363763EF-C944-4138-9710-CF483F95CD0EQ38001360-3B6B55CC-9F1C-4D33-9A0F-2429D13B98F4Q38062580-329C2C92-9FFF-4A56-A715-247A517CA0D0Q38105282-22070C60-EBFB-4481-86B5-CC108445F11DQ38176514-86872769-2B96-4E45-A3D2-F9B0EEDA9480Q38259869-188FAB33-6E55-4E57-8720-70FF978C9C69Q40125711-1F569B2A-11F2-4FC2-9576-3F55EC517275Q47223587-1C71BF2F-CAB8-4C58-AC82-EBB3D9DE6F1CQ48302673-0A89CC28-C3FA-4121-A085-29A0DED26A40Q49163329-0C64B8FC-1E16-4FDF-AC21-66A05B634ED8Q51382819-430EC399-E756-4513-885E-CC826E211DB5Q53717739-AE418B9F-38BD-4AC8-9E1D-0ABEA3C3D721
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Addressing insulin resistance in Type 1 diabetes.
@en
Addressing insulin resistance in Type 1 diabetes.
@nl
type
label
Addressing insulin resistance in Type 1 diabetes.
@en
Addressing insulin resistance in Type 1 diabetes.
@nl
prefLabel
Addressing insulin resistance in Type 1 diabetes.
@en
Addressing insulin resistance in Type 1 diabetes.
@nl
P2860
P1433
P1476
Addressing insulin resistance in Type 1 diabetes
@en
P2093
T T L Pang
P2860
P304
P356
10.1111/J.1464-5491.2008.02493.X
P577
2008-09-01T00:00:00Z